S

Seegene Inc
KOSDAQ:096530

Watchlist Manager
Seegene Inc
KOSDAQ:096530
Watchlist
Price: 23 050 KRW 1.1% Market Closed
Market Cap: 1.1T KRW
Have any thoughts about
Seegene Inc?
Write Note

Seegene Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Seegene Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Seegene Inc
KOSDAQ:096530
Cash from Financing Activities
-â‚©72.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash from Financing Activities
-â‚©273.9B
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
-18%
SK Bioscience Co Ltd
KRX:302440
Cash from Financing Activities
-â‚©89.6B
CAGR 3-Years
-288%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash from Financing Activities
-â‚©181.7B
CAGR 3-Years
-91%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Financing Activities
-â‚©17.7B
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash from Financing Activities
â‚©33.2B
CAGR 3-Years
-42%
CAGR 5-Years
39%
CAGR 10-Years
N/A
No Stocks Found

Seegene Inc
Glance View

Market Cap
1.1T KRW
Industry
Biotechnology

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. The company is headquartered in Seoul, Seoul. The company went IPO on 2010-09-10. The firm mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The firm provides its products under the brand names of Seeplex, Anyplex and Magicplex. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
18 003.22 KRW
Overvaluation 22%
Intrinsic Value
Price
S

See Also

What is Seegene Inc's Cash from Financing Activities?
Cash from Financing Activities
-72.2B KRW

Based on the financial report for Jun 30, 2024, Seegene Inc's Cash from Financing Activities amounts to -72.2B KRW.

What is Seegene Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
57%

Over the last year, the Cash from Financing Activities growth was 57%.

Back to Top